Abstract:Several aromatic amines (AA) are classified as human carcinogens, and tobacco smoke is one of the main sources of exposure. Once in the human body, they undergo different metabolic pathways which lead to either their excretion or ultimately to the formation of DNA and protein adducts. The aim of this study was to investigate AA in 68 urine samples (aged 29–79, 47% female), including 10 smokers (S), 28 past-smokers (PS) and 30 never-smokers (NS), and to study if there was a relation between the smoking status and the amount of the AA present. GCxGC-MS was used to analyze AA in complex urine samples due to its high peak capacity and the fact that it provides two sets of retention times and structural information, which facilitates the separation and identification of the target analytes. First, a qualitative comparison of an example set of a NS, PS and S sample was carried out, in which 38, 45 and 46 AA, respectively, could be tentatively identified. Afterwards, seven AA were successfully quantified in the samples. Of these, 4-ethylaniline (4EA, p = 0.015), 2,4,6-trimethylaniline (2,4,6TMA, p = 0.030), 2-naphthylamine (2NA, p = 0.014) and the sum of 2,4- and 2,6-dimethylaniline (DMA, p = 0.017) were found in significantly different (α = 0.05) concentrations for the S, 29 ± 14, 87 ± 49, 41 ± 26, and 105 ± 57 ng/L respectively, compared to the NS, 15 ± 6, 42 ± 30, 16 ± 6, and 48 ± 28 ng/L. And 2,4,6TMA (39 ± 26, p = 0.022), 2NA (18 ± 9, p = 0.025) and DMA (53 ± 46, p = 0.030), were also found at significantly higher concentrations in samples from S when compared to PS. However, some samples had AA concentrations outside the calibration curve and could not be taken into account, especially for 2-methylaniline (2MA). Therefore, all the samples were evaluated using a quantitative screening approach, by which the intensities of 4EA (p = 0.019), 2,4,6TMA (p = 0.048), 2NA (p = 0.016), DMA (p = 0.019) and 2MA (p = 0.006) in S were found to be significantly (α = 0.05) higher than in the NS, and 2MA (p = 0.019) and 4EA (p = 0.023) in S were found to be significantly higher than in the PS. An association between the smoking status and the amount of certain AA present could therefore be found. This information could be used to study the relation between the smoking status, the amount of AA present, and smoking related diseases like bladder cancer.

Screening and Identiﬁcation of the Main Metabolites of 2-Amino-9h-pyrido[2,3-b]indole (aαc) in Liver Microsomes and Rat Urine by Using UPLC-Q-TOF-MS/MS.

Comprehensive Profiling of Mercapturic Acid Metabolites from Dietary Acrylamide As Short-Term Exposure Biomarkers for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans Using Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Rapid Simultaneous Determination of Cascade Metabolites of Acrylamide in Urine for Toxicokinetics Profiles and Short-Term Dietary Internal Exposure.

UPLC/ESI-MS/MS-based Determination of Metabolism of Several New Illicit Drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and Α-Pvt, by Human Liver Microsome.

Determination of Urinary Heterocyclic Aromatic Amines in Smokers and Non-Smokers by Using Sensitive and High Throughput Liquid Chromatography-Tandem Mass Spectrometry

Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat.

Advancing metabolic networks and mapping updated urinary metabolic fingerprints after exposure to typical carcinogenic heterocyclic aromatic amines

HPLC-MS/MS Determination of the Metabolite of Acrolein in Urine

Toxicokinetics and Internal Exposure of Acrylamide: New Insight into Comprehensively Profiling Mercapturic Acid Metabolites As Short-Term Biomarkers in Rats and Chinese Adolescents.

Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro

Integrated rapid resolution liquid chromatography-tandem mass spectrometric approach for screening and identification of metabolites of the potential anticancer agent 3,6,7-trimethoxyphenanthroindolizidine in rat urine.

Liquid Chromatography/mass Spectrometry for Metabonomics Investigation of the Biochemical Effects Induced by Aristolochic Acid in Rats: the Use of Information‐dependent Acquisition for Biomarker Identification

Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples

Metabolism of Acrylamide: Interindividual and Interspecies Differences As Well As the Application As Biomarkers

Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLC–MS/MS

New Validated LC-MS/MS Method for the Determination of Three Alkylated Adenines in Human Urine and Its Application to the Monitoring of Alkylating Agents in Cigarette Smoke

Nontargeted metabolomics-based mapping urinary metabolic fingerprints after exposure to acrylamide

Identification of metabolites of adonifoline, a hepatotoxic pyrrolizidine alkaloid, by liquid chromatography/tandem and high-resolution mass spectrometry.

Liquid chromatography-tandem mass spectrometry analysis of protocatechuic aldehyde and its phase I and II metabolites in rat.

Quasi-Targeted Analysis of Hydroxylation-Related Metabolites of Polycyclic Aromatic Hydrocarbons in Human Urine by Liquid Chromatography-Mass Spectrometry

Analysis of aromatic amines in human urine using comprehensive multi-dimensional gas chromatography-mass spectrometry (GCxGC-MS)